BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28899984)

  • 61. [Primary carcinoma of the liver and Australia antigen. Contribution of a case without liver cirrhosis].
    Garcia Bengoechea M; Lanas Larrañaga E; Ortega Vega J
    Rev Clin Esp; 1974 Sep; 134(5):495-9. PubMed ID: 4373793
    [No Abstract]   [Full Text] [Related]  

  • 62. [Anatomo-clinical case].
    Prensa Med Mex; 1975; 40(3-4):104-9. PubMed ID: 168568
    [No Abstract]   [Full Text] [Related]  

  • 63. Differential diagnosis of hepatocellular nodular lesions.
    Hytiroglou P; Theise ND
    Semin Diagn Pathol; 1998 Nov; 15(4):285-99. PubMed ID: 9845429
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Differential diagnosis of hepatocellular carcinoma from metastatic tumors in the liver using microRNA expression.
    Barshack I; Meiri E; Rosenwald S; Lebanony D; Bronfeld M; Aviel-Ronen S; Rosenblatt K; Polak-Charcon S; Leizerman I; Ezagouri M; Zepeniuk M; Shabes N; Cohen L; Tabak S; Cohen D; Bentwich Z; Rosenfeld N
    Int J Biochem Cell Biol; 2010 Aug; 42(8):1355-62. PubMed ID: 20619223
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Diagnostic utility of glypican-3 for hepatocellular carcinoma on liver needle biopsy.
    Wang FH; Yip YC; Zhang M; Vong HT; Chan KI; Wai KC; Wen JM
    J Clin Pathol; 2010 Jul; 63(7):599-603. PubMed ID: 20501450
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Primary manifestation of hepatocellular carcinoma as a cervical mass.
    Karaman E; Cansiz H; Acioğlu E; Yilmazbayhan D
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(1):48-52. PubMed ID: 17483613
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Early detection of recurrent hepatocellular carcinoma by endosonographically guided fine-needle aspiration biopsy.
    Bogstad J; Vilmann P; Burcharth F
    Endoscopy; 1997 May; 29(4):322-4. PubMed ID: 9255540
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Value of computed tomography and magnetic resonance imaging in diagnosis and differential diagnosis of small hepatocellular carcinoma].
    Ma Y; Zhang XL; Li XY; Zhang L; Su HH; Zhan CY
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2235-8. PubMed ID: 19114368
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Significance of laparoscopy in the diagnosis of hepatocellular carcinoma in siderocirrhosis].
    Holzberg R; Schmidt W; Wildhirt E
    Leber Magen Darm; 1983 May; 13(3):104-7. PubMed ID: 6328140
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hep par-1: a novel immunohistochemical marker for differentiating hepatocellular carcinoma from metastatic carcinoma.
    Hanif R; Mansoor S
    J Coll Physicians Surg Pak; 2014 Mar; 24(3):186-9. PubMed ID: 24613115
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Magnetic Resonance Elastography: A Novel Technique for the Detection of Hepatic Fibrosis and Hepatocellular Carcinoma After the Fontan Operation.
    Poterucha JT; Johnson JN; Qureshi MY; O'Leary PW; Kamath PS; Lennon RJ; Bonnichsen CR; Young PM; Venkatesh SK; Ehman RL; Gupta S; Smyrk TC; Dearani JA; Warnes CA; Cetta F
    Mayo Clin Proc; 2015 Jul; 90(7):882-94. PubMed ID: 26059757
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adenomatous hyperplastic nodules in the cirrhotic liver: differentiation from hepatocellular carcinoma with MR imaging.
    Matsui O; Kadoya M; Kameyama T; Yoshikawa J; Arai K; Gabata T; Takashima T; Nakanuma Y; Terada T; Ida M
    Radiology; 1989 Oct; 173(1):123-6. PubMed ID: 2550995
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Diagnosis of hepatocellular carcinoma: role of tumor markers and liver biopsy.
    Gonzalez SA; Keeffe EB
    Clin Liver Dis; 2011 May; 15(2):297-306, vii-x. PubMed ID: 21689614
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oral metastatic cancers from hepatocellular carcinoma.
    Roh JL; Kim SY; Cho KJ; Lee SG
    J Clin Gastroenterol; 2008; 42(5):552-3. PubMed ID: 18344881
    [No Abstract]   [Full Text] [Related]  

  • 75. Hepatocellular carcinoma: Liver biopsy in the balance.
    Kleiner DE
    Hepatology; 2018 Jul; 68(1):13-15. PubMed ID: 29405373
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Invasive Ductular Reaction: Form and Function.
    Wilson DB; Rudnick DA
    Am J Pathol; 2019 Aug; 189(8):1501-1504. PubMed ID: 31202722
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Next Steps for Immune Checkpoints in Hepatocellular Carcinoma.
    Santos PM; Butterfield LH
    Gastroenterology; 2018 Dec; 155(6):1684-1686. PubMed ID: 30419214
    [No Abstract]   [Full Text] [Related]  

  • 78. Capitalising on improved rates of diagnosis of early hepatocellular carcinoma.
    Rowe IA; Sherman M
    J Hepatol; 2016 Feb; 64(2):260-261. PubMed ID: 26551515
    [No Abstract]   [Full Text] [Related]  

  • 79. Hepatocellular Carcinoma.
    Duran SR; Jaquiss RDB
    N Engl J Med; 2019 Jul; 381(1):e2. PubMed ID: 31269386
    [No Abstract]   [Full Text] [Related]  

  • 80. Hepatocellular Carcinoma.
    Kim YS; Shin SW
    N Engl J Med; 2019 Jul; 381(1):e2. PubMed ID: 31269385
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.